Clopidogrel vs Ipilimumab

Clopidogrel vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Clopidogrel and Ipilimumab.

Mechanism of Action

Clopidogrel: Irreversibly blocks P2Y12 ADP receptor on platelets.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Clopidogrel — 6 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Clopidogrel — C16H16ClNO2S.

Molecular Weight: Clopidogrel — 321.8220 g/mol.

Type: Clopidogrel — Small molecule; Ipilimumab — Antibody.